Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

Sixteen State ADAPs Have Waiting Lists, Access Restrictions, NASTAD Says

November 4, 2003

Sixteen states as of this month have waiting lists or access restrictions on their AIDS Drug Assistance Programs, with 679 people on waiting lists nationwide awaiting enrollment into ADAPs, according to the latest "ADAP Watch List" released on Monday by the National Alliance of State and Territorial AIDS Directors. ADAPs, which are state-managed, federally funded programs, provide HIV treatment to low-income, uninsured and underinsured HIV-positive individuals (NASTAD release, 11/3). According to the 2003 "National ADAP Monitoring Report," which was based on a survey by the Kaiser Family Foundation, NASTAD and the AIDS Treatment Data Network, the national ADAP budget, drug expenditures and the number of clients served by ADAPs all increased between 1996 and 2002. The number of clients served by ADAPs increased 4% in 2002, a rate of growth smaller than in previous years. ADAP drug expenditures grew to more than $70 million in June 2002 -- a 12% increase from June 2001 -- and total ADAP drug expenditures increased 370% between 1996 and 2002. The national ADAP budget reached $878.6 million in fiscal year 2002, up 8% from the year before and 366% since FY 1996 (Kaiser Daily HIV/AIDS Report, 6/24). However, federal funding for ADAPs in FY 2002 and FY 2003 has been "insufficient" to cover all qualified individuals, leading some states to impose access restrictions on the programs, according to NASTAD. Taking into account budget shortfalls, waiting lists, the addition of a new class of antiretroviral drugs and hepatitis C treatments, AIDS treatment policy experts estimate that an additional $214 million will be needed for FY 2004 to alleviate waiting lists and restrictions. However, the Senate has voted to increase ADAP funding for FY 2004 by $38.9 million and the House has voted for a $24.7 million increase, levels that "fall far short" of meeting the demand, according to NASTAD (NASTAD release, 11/3).

Back to other news for November 4, 2003


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2003 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement